AminologicsLtd Balance Sheet Health
Financial Health criteria checks 5/6
AminologicsLtd has a total shareholder equity of ₩54.4B and total debt of ₩1,000.0M, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are ₩57.7B and ₩3.3B respectively. AminologicsLtd's EBIT is ₩1.5B making its interest coverage ratio -1.7. It has cash and short-term investments of ₩28.5B.
Key information
1.8%
Debt to equity ratio
₩1.00b
Debt
| Interest coverage ratio | -1.7x |
| Cash | ₩28.50b |
| Equity | ₩54.41b |
| Total liabilities | ₩3.26b |
| Total assets | ₩57.67b |
Recent financial health updates
No updates
Recent updates
AminologicsLtd's (KOSDAQ:074430) Shareholders May Want To Dig Deeper Than Statutory Profit
Mar 27
Some Investors May Be Worried About AminologicsLtd's (KOSDAQ:074430) Returns On Capital
Mar 01Returns At AminologicsLtd (KOSDAQ:074430) Are On The Way Up
May 05Should Weakness in Aminologics Co.,Ltd.'s (KOSDAQ:074430) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Mar 19If You Had Bought AminologicsLtd (KOSDAQ:074430) Stock Five Years Ago, You Could Pocket A 137% Gain Today
Feb 04Financial Position Analysis
Short Term Liabilities: A074430's short term assets (₩45.2B) exceed its short term liabilities (₩2.7B).
Long Term Liabilities: A074430's short term assets (₩45.2B) exceed its long term liabilities (₩589.5M).
Debt to Equity History and Analysis
Debt Level: A074430 has more cash than its total debt.
Reducing Debt: A074430's debt to equity ratio has reduced from 1.9% to 1.8% over the past 5 years.
Debt Coverage: A074430's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: A074430 earns more interest than it pays, so coverage of interest payments is not a concern.